8月26日再鼎医药在港交所公告上半年产品收入净额同比增加15%至2.15亿美元;研发开支同比减少4%至1.11亿美元;亏

智通财经
10 hours ago
8月26日再鼎医药在港交所公告上半年产品收入净额同比增加15%至2.15亿美元;研发开支同比减少4%至1.11亿美元;亏损净额较上年同期减少4460万美元至8920万美元主要由于收入增长快于净营运开支;每股基本及摊薄亏损为0.08美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10